• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIHR launches first two translational partnerships in U.K.

NIHR launches first two translational partnerships in U.K.

October 11, 2011
CenterWatch Staff

NIHR translational research partnerships bring together investigators at the U.K.’s leading academic and NHS centers to support collaboration with the life sciences industry in early and exploratory development of new drugs and other interventions.

The research centers that make up the partnerships have been selected to work together based on their proven ability to deliver in experimental medicine and translational research. As members of a partnership, each center has committed to work with industry through a consistent point of contact provided by the NIHR office for clinical research infrastructure (NOCRI).

NIHR has launched the first two translational research partnerships, focusing on joint and related inflammatory diseases, including rheumatoid arthritis, osteoarthritis and synovitis, and inflammatory respiratory disease including asthma, allergy, COPD, cystic fibrosis, acute lung injury and respiratory infection.

Translational research partnerships offer an internationally unique approach to support open innovation and collaboration with the life sciences industries.  Collectively they bring together recognized experience in current exploratory development protocols, expertise in pathophysiology and disease mechanisms and expertise in modeling. They enable technologies and infrastructure, including imaging, biobanks and accredited laboratory facilities. They also offer cohorts of well-characterized patients available for clinical development studies.

Further partnerships will be developed. NOCRI is working with a range of stakeholders to assess which disease and theraputic areas would benefit from this approach. NIHR biomedical research centers and units provide the bedrock of the first two NIHR partnerships and will form the basis of future partnerships.

Upcoming Events

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

  • 25May

    How Can the Accelerated Availability of Pfizer-BioNTech’s COVID-19 Vaccine be Replicated?

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing